LDT (Tyzeka 600 mg)

Generic Name: telbivudine

Pill imprint LDT has been identified as Tyzeka 600 mg.

Tyzeka is used in the treatment of hepatitis b and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Tyzeka 600 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for LDT (Tyzeka 600 mg)

Tyzeka 600 mg LDT
Tyzeka
Generic Name:
telbivudine
Imprint:
LDT
Strength:
600 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Novartis Corporation

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web1)